Abstract
In recent years the interest in stem cell-based therapies for gastrointestinal injury has been increasing continuously. From the clinical point of view, transplantation of bone marrow derived stem cells may represent an alternative therapy for gastrointestinal injury, such as radioactive injury, inflammatory bowel disease, and other refractory gastrointestinal tract injury. There were several reports indicated that bone marrow derived stem cells located in the injured gastrointestinal tract and contributed to its regeneration by differentiating into functional epithelia cells or infusing with the gastrointestinal stem cells. Although the concept of cell-based therapy for various diseases of the gastrointestinal is widely accepted, the practical approach in humans remains difficult. Here we discussed the recent published data on clinical and experimental bone marrow stem cell transplantation and the possible role of stem cells in gastrointestinal tissue repair.
Similar content being viewed by others
References
Ayala, A., Song, G. Y., Chung, C. S., Redmond, K. M., & Chaudry, I. H. (2000). Immune depression in polymicrobial sepsis: The role of necrotic (injured) tissue and endotoxin. Critical Care Medicine, 28, 2949–2955. doi:10.1097/00003246-200008000-00044.
Nussler, N. C., Muller, A. R., Weidenbach, H., Vergopoulos, A., Platz, K. P., Volk, H. D., et al. (2003). IL-10 increases tissue injury after selective intestinal ischemia/reperfusion. Annals of Surgery, 238, 49–58. doi:10.1097/00000658-200307000-00007.
Ford, H. R. (2006). Mechanism of nitric oxide-mediated intestinal barrier failure: Insight into the pathogenesis of necrotizing enterocolitis. Journal of Pediatric Surgery, 41, 294–299. doi:10.1016/j.jpedsurg.2005.11.003.
Neal, M. D., Leaphart, C., Levy, R., Prince, J., Billiar, T. R., Watkins, S., et al. (2006). Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. Journal of Immunology, 176, 3070–3079.
Cetin, S., Leaphart, C. L., Li, J., Ischenko, I., Hayman, M., Upperman, J., et al. (2006). Nitric oxide inhibits enterocyte migration through activation of RhoA-GTPase in a SHP-2-dependent manner. American Journal of Physiology: Gastrointestinal and Liver Physiology, 292, G1347–G1358. doi:10.1152/ajpgi.00375.2006.
Khalil, P. N., Weiler, V., Nelson, P. J., Khalil, M. N., Moosmann, S., Mutschler, W. E., et al. (2007). Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology, 132, 944–954. doi:10.1053/j.gastro.2006.12.029.
Haider, H., & Ashraf, M. (2005). Bone marrow cell transplantation in clinical perspective. Journal of Molecular and Cellular Cardiology, 38, 225–235. doi:10.1016/j.yjmcc.2004.12.005.
Nagy, R. D., Tsai, B. M., Wang, M., Markel, T. A., Brown, J. W., & Meldrum, D. R. (2005). Stem cell transplantation as a therapeutic approach to organ failure. Journal of Surgical Research, 129, 152–160. doi:10.1016/j.jss.2005.04.016.
Krause, D. S., Theise, N. D., Collector, M. I., Henegariu, O., Hwang, S., Gardner, R., et al. (2001). Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell, 105, 369–377. doi:10.1016/S0092-8674(01)00328-2.
Lagasse, E., Connors, H., & Al-Dhalimy, M. (2000). Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nature Medicine, 6, 1229–1234. doi:10.1038/81326.
Bengala, C., Guarneri, V., & Giovannetti, E. (2005). Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma. British Journal of Cancer, 93, 35–40. doi:10.1038/sj.bjc.6602673.
Brazelton, T. R., Rossi, F. M., & Keshet, G. I. (2000). From marrow to brain: Expression of neuronal phenotypes in adult mice. Science, 290, 1775–1779. doi:10.1126/science.290.5497.1775.
Goodell, M. A., Jackson, K. A., Majka, S. M., Mi, T., Wang, H., Pocius, J., et al. (2001). Stem cell plasticity in muscle and bone marrow. Annals of the New York Academy of Sciences, 938, 208–218.
Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., et al. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. Journal of Clinical Investigation, 107, 1395–1402. doi:10.1172/JCI12150.
Orlic, D., Kajstura, J., & Chimenti, S. (2001). Bone marrow cells regenerate infracted myocardium. Nature, 410, 701–705. doi:10.1038/35070587.
Okamoto, R., Yajima, T., Yamazaki, M., Kanai, T., Mukai, M., Okamoto, S., et al. (2002). Damaged epithelial regenerated by bone marrow derived cells in the human gastrointestinal tract. Nature Medicine, 8, 1011–1017. doi:10.1038/nm755.
Kayahara, T., Sawada, M., Takaishi, S., Fukui, H., Seno, H., Fukuzawa, H., et al. (2003). Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Letters, 535, 131–135. doi:10.1016/S0014-5793(02)03896-6.
Booth, C., & Potten, C. S. (2000). Gut instincts: Thoughts on intestinal epithelial stem cells. Journal of Clinical Investigation, 105, 1493–1499. doi:10.1172/JCI10229.
Markel, T. A., Crisostomo, P. R., Lahm, T., Novotny, N. M., Rescorla, F. J., Tector, J., et al. (2008). Stem cells as a potential future treatment of pediatric intestinal disorders. Journal of Pediatric Surgery, 43, 1953–1963. doi:10.1016/j.jpedsurg.2008.06.019.
Dekaney, C. M., Rodriguez, J. M., Graul, M. C., & Henning, S. J. (2005). Isolation and characterization of a putative intestinal stem cell fraction from mouse jejunum. Gastroenterology, 129, 1567–1580. doi:10.1053/j.gastro.2005.08.011.
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., & van den Born, M. (2009). Crypt stem cells as the cells-of-origin of intestinal cancer. Nature, 457, 608–611. doi:10.1038/nature07602.
Yen, T. H., & Wright, N. A. (2006). The gastrointestinal tract stem cell niche. Stem Cell Rev, 2, 203–212. doi:10.1007/s12015-006-0048-1.
Brittan, M., & Wright, N. A. (2004). Stem cell in gastrointestinal structure and neoplastic development. Gut, 53, 899–910. doi:10.1136/gut.2003.025478.
Brittan, M., Hunt, T., Jeffery, R., Poulsom, R., Forbes, S. J., Hodivala-Dilke, K., et al. (2002). Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut, 50, 752–757. doi:10.1136/gut.50.6.752.
Okamoto, R., & Watanabe, M. (2003). Prospects for regeneration of gastrointestinal epithelia using bone marrow cells. Trends in Molecular Medicine, 9, 286–290. doi:10.1016/S1471-4914(03)00110-2.
Resbeut, M., Marteau, P., Cowen, D., Richaud, P., Bourdin, S., Dubois, J. B., et al. (1997). A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis. Radiotherapy and Oncology, 44, 59–63. doi:10.1016/S0167-8140(97)00064-9.
Chen, S. W., Liang, J. A., Yang, S. N., Hung, Y. C., Yeh, L. S., Shiau, A. C., et al. (2004). Radiation injury to intestine following hysterectomy and adjuvant radiotherapy for cervical cancer. Gynecologic Oncology, 95, 208–214. doi:10.1016/j.ygyno.2004.07.003.
Carr, K. E., Hume, S. P., Nelson, A. C., O’Shea, O., Hazzard, R. A., & McCullough, J. S. (1996). Morphological profiles of neutron and X-irradiated small intestine. Journal of Radiation Research (Tokyo), 37, 38–48. doi:10.1269/jrr.37.38.
Crook, J., Esche, B., & Futter, N. (1996). Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: The patient’s perspective. Urology, 47, 387–394. doi:10.1016/S0090-4295(99)80458-0.
Zhang, J., Gong, J. F., Zhang, W., Zhu, W. M., & Li, J. S. (2008). Effects of transplanted bone marrow mesenchymal stem cells on the irradiated intestine of mice. Journal of Biomedical Science, 15, 585–594. doi:10.1007/s11373-008-9256-9.
Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 418, 41–49. doi:10.1038/nature00870.
Devine, S. M., Cobbs, C., Jennings, M., Bartholomew, A., & Hoffman, R. (2003). Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood, 101, 2999–3001. doi:10.1182/blood-2002-06-1830.
Semont, A., Francois, S., Mouiseddine, M., Francois, A., Sache, A., Frick, J., et al. (2007). Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury. Advances in Experimental Medicine and Biology, 585, 19–30. doi:10.1007/978-0-387-34133-0_2.
Okamoto, R., Matsumoto, T., & Watanabe, M. (2006). Regeneration of the intestinal epithelial: Regulation of bone marrow-derived epithelial cell differentiation towards secretory lineage cells. Human Cell, 19, 71–75. doi:10.1111/j.1749-0774.2006.00010.x.
Sands, B. E. (2007). Infammatory bowel disease: Past, present, and future. Journal of Gastroenterology, 42, 16–25. doi:10.1007/s00535-006-1995-7.
Kashyap, A., & Forman, S. J. (1998). Autologous bone marrow transplantation for non-Hodgkin’s lymphoma resulting in long term remission of coincidental Crohn’s disease. British Journal of Haematology, 103, 651–652. doi:10.1046/j.1365-2141.1998.01059.x.
Lopez-Cubero, S. O., Sullivan, K. M., & McDonald, G. B. (1998). Course of Crohn’s disease after allogeneic marrow transplantation. Gastroenterology, 114, 433–440. doi:10.1016/S0016-5085(98)70525-6.
Ditschkowski, M., Einsele, H., Schwerdtfeger, R., Bunjes, D., Trenschel, R., Beelen, D. W., et al. (2003). Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation. Transplantation, 75, 1745–1747. doi:10.1097/01.TP.0000062540.29757.E9.
Oyama, Y., Craig, R. M., Traynor, A. E., Quigley, K., Statkute, L., Halverson, A., et al. (2005). Autologous hematopoietic stem cell transplantation in patients with refractory Crohn’s disease. Gastroenterology, 128, 552–563. doi:10.1053/j.gastro.2004.11.051.
Cassinotti, A., Annaloro, C., Ardizzone, S., Onida, F., Della Volpe, A., Clerici, M., et al. (2008). Autologous haematopoietic stem cell transplantation without CD34 + cell selection in refractory Crohn’s disease. Gut, 57, 211–217. doi:10.1136/gut.2007.128694.
Mitsuyama, K., Andoh, A., Masuda, J., Yamasaki, H., Kuwaki, K., Takedatsu, H., et al. (2008). Mobilization of bone marrow cells by leukocytapheresis in patients with ulcerative colitis. Ther Apher Dial, 12, 271–277. doi:10.1111/j.1744-9987.2008.00587.x.
Padron Velazquez, J. L. (2006). Stem cell fusion as an ultimate line of defense against xenobiotics. Medical Hypotheses, 67, 383–387. doi:10.1016/j.mehy.2006.01.031.
Ambrosi, D. J., & Rasmussen, T. P. (2005). Reprogramming mediated by stem cell fusion. Journal of Cellular and Molecular Medicine, 9, 320–330. doi:10.1111/j.1582-4934.2005.tb00358.x.
Rizvi, A. Z., Swain, J. R., Davies, P. S., Bailey, A. S., Decker, A. D., Willenbring, H., et al. (2006). Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proceedings of the National Academy of Sciences of the United States of America, 103, 6321–6325. doi:10.1073/pnas.0508593103.
Matsumoto, T., Okamoto, R., Yajima, T., Mori, T., Okamoto, S., Ikeda, Y., et al. (2005). Increase of bone marrow-derived secretory lineage epithelial cells during regeneration in the human intestine. Gastroenterology, 128, 1851–1867. doi:10.1053/j.gastro.2005.03.085.
Fishbein, T., Novitskiy, G., Mishra, L., Matsumoto, C., Kaufman, S., Goyal, S., et al. (2007). NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut, 57, 323–330. doi:10.1136/gut.2007.133322.
Author information
Authors and Affiliations
Corresponding author
Additional information
Li Yan and Changhao Cai are co-first author
Rights and permissions
About this article
Cite this article
Yan, L., Cai, C., Li, J. et al. Present Status and Perspectives of Stem Cell-Based Therapies for Gastrointestinal Diseases. Stem Cell Rev and Rep 5, 278–282 (2009). https://doi.org/10.1007/s12015-009-9070-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-009-9070-4